They demonstrated that DARS-AS1 is regulated by HIF-1α and that DARS-AS1 regulates mTOR signaling via RBM39, thus concluding that the HIF1α/DARS-AS1/RBM39 axis could be a useful target in multiple myeloma. Here, RBM39 is linked to AL amyloidosis.